Literature DB >> 33563561

Molecular characterization of Clostridioides difficile ribotype 027 in a major Chinese hospital.

Ren-Feng Zhang1, Yu-Xia Man2, Yuan-Yuan Bai1, Chun-Hong Shao1, Chun-Mei Liu1, Cong-Hui Wang3, Yong-Xing Lei4, Yong Wang5, Yan Jin6.   

Abstract

BACKGROUND: The rapid spread of C. difficile 027 has become one of the leading threats of healthcare-associated infections wordwild. However, C. difficile 027 infections have rarely been reported in China. The objective of this study was to strengthen the understanding of the molecular characterizations of C. difficile 027 in China.
METHODS: In this study, stool specimens from 176 suspected CDI cases were collected from 1 Jan 2018 to 30 Jun 2019. These specimens were measured by GeneXpert test and C.difficile colonies were identified and analyzed.
RESULTS: There were five samples positive for tcdA, tcdB, binary toxin genes and had deletions in tcdC gene. These five Clostridioides difficile isolates belonged to ST1 and confirmed as Clostridioides difficile 027 strains by PCR ribotyping. Through using whole genome sequencing, , we found that these five strains were closely clustered into the same predominant evolutionary branch and were highly similar to C. difficile 027 strain R20291. Antimicrobial susceptibility testing result showed they were highly resistant to fluoroquinolones.
CONCLUSIONS: In Our study, five C. difficile 027 isolates were identified and characterized using MLST, PCR ribotyping and whole genome sequencing. We proposed that C. difficile 027 infections are probably neglected in China. Further epidemiological studies across the country together with the introduction of routine diagnostic testing and multi-center or national level surveillance are needed to ascertain the size of this potentially significant problem.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Antimicrobial resistance; China; Clostridioides difficile; Multilocus sequence typing; PCR RT027; Whole genome sequence

Mesh:

Substances:

Year:  2021        PMID: 33563561     DOI: 10.1016/j.jmii.2021.01.003

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

1.  The cwp66 Gene Affects Cell Adhesion, Stress Tolerance, and Antibiotic Resistance in Clostridioides difficile.

Authors:  Qingshuai Zhou; Fengqin Rao; Zhenghong Chen; Yumei Cheng; Qifang Zhang; Jie Zhang; Zhizhong Guan; Yan He; Wenfeng Yu; Guzhen Cui; Xiaolan Qi; Wei Hong
Journal:  Microbiol Spectr       Date:  2022-03-31

2.  Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.

Authors:  Ching-Chi Lee; Jen-Chieh Lee; Chun-Wei Chiu; Pei-Jane Tsai; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Microbiol Spectr       Date:  2021-10-20

3.  Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus.

Authors:  Jen-Chieh Lee; Chun-Wei Chiu; Pei-Jane Tsai; Ching-Chi Lee; I-Hsiu Huang; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Biosci Microbiota Food Health       Date:  2021-11-03

Review 4.  Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents.

Authors:  Chun-Wei Chiu; Pei-Jane Tsai; Ching-Chi Lee; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Pathogens       Date:  2021-05-24

5.  Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice.

Authors:  Bo-Yang Tsai; Yi-Hsin Lai; Chun-Wei Chiu; Chih-Yu Hsu; Yi-Hsuan Chen; Yueh-Lin Chen; Pei-Jane Tsai; Yuan-Pin Hung; Wen-Chien Ko
Journal:  Antibiotics (Basel)       Date:  2022-01-17

6.  The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients.

Authors:  Yi-Hsin Lai; Bo-Yang Tsai; Chih-Yu Hsu; Yi-Hsuan Chen; Po-Han Chou; Yueh-Lin Chen; Hsiao-Chieh Liu; Wen-Chien Ko; Pei-Jane Tsai; Yuan-Pin Hung
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.